INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 04,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 833
INFLAMMATORY MARKERS AND THEIR DIAGNOSTIC SIGNIFICANCE IN
ACUTE INFLAMMATION
Rakhmanov Shokhzodbek
Assistant of the Department of Pathology and Forensic Medicine,
Central Asian Medical University
Anvarov Husanboy
Central Asian Medical University, 2nd year student of Medical Science
Xomidov Elyor
Central Asian Medical University, 2nd year student of Medical Science
Abstract:
This article covers the topic "Inflammatory markers and their diagnostic
significance in acute inflammation". The article analyzes in detail the physiological basis of
inflammatory processes, clinical manifestations of acute inflammation and the role of
diagnostic markers. In particular, information is provided about inflammatory markers such
as C-reactive protein, procalcitonin, pentraxin 3 and serum amyloid A. These markers are
important in determining the intensity, cause and prognosis of inflammation. The article
highlights the clinical significance of these markers in the effective management and
treatment of inflammatory processes.
Keywords:
Inflammation, Inflammatory markers, C-reactive protein, Procalcitonin, Systemic
effects of inflammation, Stages of inflammation, Procalcitonin, Interleukins.
Аннотация:
В статье рассматривается тема «Маркеры воспаления и их
диагностическое значение при остром воспалении». В статье подробно анализируются
физиологические основы воспалительных процессов, клинические проявления острого
воспаления,
роль диагностических
маркеров.
В
частности,
представлена
информация о маркерах воспаления, таких как С-реактивный белок,
прокальцитонин, пентраксин 3 и сывороточный амилоид А. Эти маркеры важны для
определения интенсивности, причины и прогноза воспаления. В статье подчеркивается
клиническая значимость этих маркеров в эффективном контроле и лечении
воспалительных процессов.
Ключевые слова:
Воспаление,
Маркеры
воспаления,
С-реактивный
белок,
Прокальцитонин,
Системные
эффекты
воспаления,
Стадии
воспаления,
Прокальцитонин, Интерлейкины.
Introduction
Inflammation is one of the main protective reactions of the div against external and
internal harmful factors. The inflammatory process occurs as a result of infectious agents
(bacteria, viruses, fungi), mechanical damage, chemicals, toxins, and even an incorrect
response of the immune system to its own tissues. The main function of inflammation is to
protect damaged or infected tissues, eliminate harmful factors, and initiate tissue regeneration.
Inflammation is clinically manifested as a central pathogenetic element of many diseases. In
particular, acute inflammatory conditions - diseases such as pneumonia, appendicitis,
pancreatitis, sepsis - require early and accurate diagnosis. In such cases, it is important to
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 04,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 834
identify and control the inflammatory process using laboratory indicators, not limited to
clinical symptoms (fever, pain, swelling).
Inflammatory markers are a set of substances that change in the blood and other
biological fluids when an inflammatory process develops in the div. These include, first of
all, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), procalcitonin (PCT),
interleukins, tumor necrosis factor (TNF-α), fibrinogen, ferritin and many other markers.
These indicators make it possible to determine the presence, severity, stage, and sometimes
the etiological factor of inflammation. Currently, in medical practice, the determination of
inflammatory markers has become an integral part of the diagnostic process. For example, an
increase in the level of C-reactive protein is characteristic of bacterial infections, and an
increase in procalcitonin is characteristic of sepsis and severe infectious conditions. At the
same time, each marker has its own characteristics, level of accuracy and clinical limitations,
and their correct interpretation requires deep knowledge and experience from the doctor. The
diagnostic value of inflammatory markers plays a major role not only in diagnosing the
disease, but also in assessing and predicting the effectiveness of treatment. By monitoring
their dynamics, doctors can assess the development of the disease or the recovery process,
and change treatment methods in a timely manner.
Literature review and method
Inflammation is a complex biological process that develops as a protective reaction of
the div, aimed at combating external and internal harmful factors and restoring damaged
tissues. Inflammation plays a key role in protecting the div from factors such as infectious
agents, mechanical damage, chemicals and toxins.
Inflammation is manifested in clinical practice as the main pathogenetic mechanism
of many diseases. In particular, acute inflammatory conditions - diseases such as acute
pneumonia, acute appendicitis, acute pancreatitis, sepsis - require early and accurate
diagnosis. In such cases, it is necessary to identify and control the inflammatory process
using laboratory indicators, not limited only to clinical signs.
Inflammatory markers are biological substances that change in quantity in the blood and
other biological fluids when an inflammatory process develops in the div. These markers
make it possible to determine the presence of the inflammatory process, its intensity, duration,
and sometimes the cause of the inflammation.
The main types of inflammatory markers are:
C-reactive protein is a protein produced in the liver and increases rapidly in the blood
during the early stages of the inflammatory reaction. Increased levels of C-reactive protein
are often associated with bacterial infections, autoimmune diseases, and tissue necrosis. C-
reactive protein is a very sensitive and variable marker for assessing the intensity of
inflammation.
Erythrocyte sedimentation rate - this method measures the rate at which erythrocytes
settle in plasma. The erythrocyte sedimentation rate increases in inflammation and other
pathological processes. Although this indicator is not an accurate diagnostic tool, it is useful
in monitoring chronic and acute inflammatory conditions.
Procalcitonin is a protein that is normally present in very low levels in the blood, but its
levels increase dramatically in bacterial infections and sepsis. Elevated levels of procalcitonin
are important in differentiating bacterial from viral infections.
Interleukins are cytokines produced by immune system cells that are involved in
regulating the immune response and promoting inflammation. Interleukin-6 levels in
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 04,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 835
particular are considered important markers for assessing the severity of the inflammatory
process. Tumor necrosis factor alpha is a cytokine that plays an important role in the
initiation and progression of inflammation. Tumor necrosis factor alpha levels are
particularly elevated in severe infections and sepsis. Ferritin is a protein that stores iron in the
div, and its levels increase during inflammation. Ferritin helps assess the intensity of
inflammation and the severity of the disease. Fibrinogen is a protein present in plasma that is
involved in blood clotting, and its levels increase during inflammatory reactions. Fibrinogen
is also considered a risk factor for cardiovascular disease.
Markers of inflammation are important laboratory indicators for determining the
presence of an inflammatory process in the div, assessing its level and activity. These
markers can be used to detect the disease at an early stage, determine its severity, monitor the
effectiveness of treatment, and assess the prognosis.
The diagnostic value of markers of inflammation primarily allows for early diagnosis of the
disease. Markers such as C-reactive protein and procalcitonin increase their levels in the first
hours of the inflammatory reaction. This makes it possible to diagnose the disease and take
prompt medical measures before the patient has fully developed clinical symptoms.
The second aspect is that inflammatory markers help assess the severity of the
inflammatory process. High levels of C-reactive protein, Interleukin-6, and procalcitonin
indicate a strong course of inflammation in the div. This, in turn, signals the doctor to
assess the patient's general condition and the need for intensive treatment.
The third important aspect is that inflammatory markers are used to monitor the effectiveness
of the treatment process. If the level of inflammatory markers decreases as a result of the
prescribed treatment, this indicates that the treatment method has been chosen correctly. On
the contrary, if the level of markers does not decrease or increases again, it is necessary to
reconsider the treatment strategy.
The fourth importance is that inflammatory markers can be used to determine the
nature of infectious agents. For example, procalcitonin levels are elevated in bacterial
infections, while no significant changes are observed in viral infections. This plays an
important role in determining the need for antibiotic therapy.
Fifth, inflammatory markers allow us to assess the prognosis of the disease. If the level of
inflammatory markers is very high, this may indicate a severe course of the disease or the
development of complications. To correctly interpret inflammatory markers in clinical
practice, their level must be evaluated in conjunction with the patient's clinical symptoms,
instrumental examination results, and other laboratory indicators. Because inflammatory
markers only indicate the existing inflammatory state, but cannot determine its exact cause or
location.
Discussion
Although inflammation is a natural biological process that occurs as a protective
reaction of the div, its untimely detection or incorrect assessment can lead to many serious
complications. Therefore, the detection of inflammatory markers and making clinical
decisions based on their results play an important role in modern medicine.
Inflammatory markers, in particular, such as C-reactive protein, procalcitonin, and
Interleukin-6, allow not only to determine the presence of inflammation, but also to assess its
level and dynamics of development. In acute inflammatory conditions, such as acute
pneumonia, appendicitis, or sepsis, these markers are an integral part of diagnostics. Studies
and clinical experiences show that increased levels of C-reactive protein and procalcitonin
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 04,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 836
allow for the early detection of acute bacterial infections. In particular, procalcitonin is used
as an accurate and reliable marker in the differential diagnosis of bacterial and viral
infections. Also, the levels of cytokines such as Interleukin-6 and Tumor necrosis factor
alpha increase significantly during severe infection and inflammation.
However, it is necessary to take into account some of their limitations when assessing
inflammatory markers. For example, C-reactive protein can be increased in many different
conditions, including autoimmune diseases, injuries, and even some non-inflammatory
conditions. This requires that markers be interpreted not only as laboratory indicators, but
also taking into account the clinical picture.
Another important point in the discussion is that inflammatory markers can greatly help in
monitoring the treatment process. A decrease in the level of C-reactive protein or
procalcitonin indicates that the inflammatory process in the patient has subsided and the
treatment is effective. Conversely, persistently high or increasing levels of markers indicate
disease progression or non-response to treatment.
Inflammatory markers can also be used to assess the prognosis of the disease. For
example, high levels of procalcitonin and Interleukin-6 indicate a high risk of developing
severe sepsis or septic shock. This indicates to the doctor the need to monitor the patient in
intensive care or take more aggressive treatment measures. In general, inflammatory markers
provide great opportunities in clinical practice for early diagnosis of diseases, assessment of
the treatment process and determination of the patient's prognosis. Their correct interpretation
and evaluation in combination with other clinical data allows choosing the most optimal and
effective treatment strategy for the patient. Therefore, accepting inflammatory markers as an
integral part of the diagnostic process and carefully approaching their results is an important
requirement of modern medicine.
Results
Inflammatory markers are of great diagnostic importance in identifying acute
inflammatory processes, assessing the severity of the disease, monitoring and predicting the
effectiveness of treatment. Key markers such as C-reactive protein, procalcitonin, and
Interleukin-6 show significant changes in the early stages of the inflammatory process,
supporting clinical diagnosis and helping the doctor make quick decisions. By assessing the
level of inflammatory markers, the possibility of determining the etiology of the infectious
process, controlling the course of the disease, and preventing complications increases.
Monitoring based on markers allows you to improve the patient's general condition and apply
the necessary treatment measures in a timely manner.
Therefore, inflammatory markers play an invaluable role in clinical practice in the
correct and early detection of inflammatory processes, developing an effective treatment
strategy, and improving the patient's quality of life. In the future, the introduction of new and
more sensitive markers is expected to further expand diagnostic capabilities in this regard.
Conclusion
Inflammatory markers are of fundamental importance in modern laboratory
diagnostics for early detection of inflammatory processes, assessment of their severity, and
monitoring the effectiveness of treatment. Studies show that the levels of C-reactive protein,
procalcitonin, Interleukin-6, and other biomarkers change significantly in acute and chronic
inflammatory conditions, which serves as an important diagnostic and prognostic indicator in
clinical decision-making. Timely and correct interpretation of inflammatory markers allows
for differential diagnosis of infectious and non-infectious inflammatory processes,
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 04,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 837
assessment of the course of the disease, and development of an individual treatment strategy.
Some markers, such as procalcitonin, show high sensitivity and specificity in distinguishing
bacterial infections from viral infections, while C-reactive protein shows high sensitivity and
specificity in determining the overall inflammatory activity.
Based on scientific sources and clinical experience, it has been established that
inflammatory markers also play an important role in assessing the patient's prognosis. High
levels of markers are considered an independent predictor of the development of severe
diseases and complications. Therefore, in clinical practice, it is necessary to use inflammatory
markers in a comprehensive approach, in combination with other laboratory and instrumental
examinations.
References:
1. Gabay C., Kushner I. (1999). "Acute-phase proteins and other systemic responses to
inflammation." New England Journal of Medicine, 340(6), 448-454.
2. Baumann H., Gauldie J. (1994). "The acute phase response." Immunology Today, 15(2),
74-80.
3. Veas F. (2011). "Acute Phase Proteins as Early Non-Specific Biomarkers of Human and
Veterinary Diseases." BoD – Books on Demand.
4. Baumann H., Mackiewicz A., Kushner I. (2020). "Acute Phase Proteins: Molecular
Biology, Biochemistry, and Clinical Applications." Taylor & Francis.
5. Whicher J., Banks R., Thompson D., Evans S. (2020). "The Measurement of Acute
Phase Proteins as Disease Markers." In: Acute Phase Proteins: Molecular Biology,
Biochemistry, and Clinical Applications. Taylor & Francis.
6. Shukhratov Sh. (2020). "Clinic and differential diagnosis of inflammatory diseases of the
salivary glands." Litres.
7. Sizov V. (2020). "Evaluation of the diagnostic and prognostic significance of cytokine
dynamics in infants with systemic inflammatory response syndrome." Sammu e-library.
8. Qodirov A., Tursunov B. (2020). "Study of the correlation between parameters of blood
inflammatory markers and rosacea."
